# Ivabradine in Hemodialysed Patients With Increased Heart Rate

Study · id `cardio:ct-nct01364077` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01364077](<https://clinicaltrials.gov/study/NCT01364077>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01364077

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01364077. Randomized; triple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01364077, source copy `cardio:ctgov-nct01364077-2012-06-21`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01364077, source copy `cardio:ctgov-nct01364077-2012-06-21`, retrieved 2026-10-26)
- Primary completion: 2011-01 (actual) (ClinicalTrials.gov record NCT01364077, source copy `cardio:ctgov-nct01364077-2012-06-21`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Italy (ClinicalTrials.gov record NCT01364077, source copy `cardio:ctgov-nct01364077-2012-06-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01364077-2012-06-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ivabradine in Hemodialysed Patients With Increased Heart Rate
- Condition: High Heart Rate
- Intervention (Drug): Ivabradine
- Intervention (Drug): Placebo
- Lead sponsor: University of Campania Luigi Vanvitelli
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: University of Campania Luigi Vanvitelli (`cardio:org-university-of-campania-luigi-vanvitelli`)

## Provenance

Content hash: 49e4a32642a4a11dc1fc6edf608d412109406ae5e4776d2884b93e2eb18a3756
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
